Chien-Fu Hung Selected Research

Papilloma (Papillomatosis)

1/2024	Profiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory Papillomatosis.
1/2018	Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus.
1/2017	Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chien-Fu Hung Research Topics

Disease

175	Neoplasms (Cancer) 04/2024 - 03/2002
26	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2007
25	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2007
24	Infections 04/2024 - 03/2003
21	Papillomavirus Infections 04/2024 - 01/2003
9	Communicable Diseases (Infectious Diseases) 01/2022 - 02/2003
9	Vaccinia 01/2021 - 11/2002
7	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 03/2011
6	Carcinogenesis 04/2024 - 07/2007
4	Carcinoma (Carcinomatosis) 10/2022 - 01/2003
4	Tuberculosis (Tuberculoses) 10/2021 - 11/2016
3	Ovarian Epithelial Carcinoma 01/2024 - 12/2017
3	Papilloma (Papillomatosis) 01/2024 - 01/2017
3	Recurrent respiratory papillomatosis 01/2024 - 11/2010
3	COVID-19 10/2023 - 12/2020
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 07/2017
3	Leiomyoma (Uterine Fibroids) 03/2021 - 10/2003
3	Condylomata Acuminata (Genital Wart) 01/2021 - 11/2014
3	Uterine Cervical Dysplasia 01/2021 - 02/2016
3	Melanoma (Melanoma, Malignant) 01/2021 - 02/2012
3	Ascites 01/2020 - 07/2007
3	Virus Diseases (Viral Diseases) 03/2010 - 09/2003
2	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2020
2	Thrombosis (Thrombus) 09/2022 - 12/2015
2	Squamous Cell Carcinoma of Head and Neck 04/2022 - 01/2022
2	Head and Neck Neoplasms (Head and Neck Cancer) 09/2021 - 12/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 02/2007
2	Multiple Myeloma 01/2021 - 01/2015
2	Skin Neoplasms (Skin Cancer) 01/2018 - 07/2013
2	Inflammation (Inflammations) 09/2016 - 03/2015
2	Hyperthermia 09/2015 - 01/2013
2	Pancreatitis 03/2015 - 01/2009

Drug/Important Bio-Agent (IBA)

71	AntigensIBA 01/2024 - 03/2002
56	DNA VaccinesIBA 10/2023 - 03/2002
54	VaccinesIBA 10/2022 - 01/2003
50	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 03/2002
38	Proteins (Proteins, Gene)FDA Link 08/2022 - 03/2002
25	Therapeutic UsesIBA 10/2023 - 04/2007
23	Papillomavirus Vaccines (HPV Vaccines)IBA 09/2021 - 01/2007
20	Peptides (Polypeptides)IBA 10/2022 - 03/2003
16	A-Form DNA (A-DNA)IBA 01/2021 - 05/2004
15	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 11/2002
12	CalreticulinIBA 01/2020 - 08/2004
10	EpitopesIBA 01/2024 - 03/2003
10	LuciferasesIBA 10/2022 - 07/2007
10	Oncogene Proteins (Oncogene Protein)IBA 04/2021 - 07/2006
10	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2008
6	LigandsIBA 01/2024 - 04/2009
5	Immune Checkpoint InhibitorsIBA 11/2023 - 12/2017
5	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2022 - 01/2007
5	Interleukin-2 (IL2)IBA 08/2022 - 12/2007
5	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2015
5	MesothelinIBA 01/2018 - 01/2007
4	AntibodiesIBA 01/2024 - 08/2008
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
4	UbiquitinIBA 01/2021 - 10/2016
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2010
4	Bortezomib (Velcade)FDA Link 01/2021 - 08/2008
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2014 - 01/2013
3	Immunoglobulin G (IgG)IBA 01/2024 - 02/2013
3	AutoantigensIBA 01/2024 - 02/2013
3	Sorafenib (BAY 43-9006)FDA Link 09/2022 - 01/2018
3	TransposasesIBA 09/2021 - 01/2018
3	Annexin A5IBA 01/2021 - 09/2016
3	PiperidonesIBA 01/2021 - 10/2016
3	Imiquimod (Aldara)FDA LinkGeneric 01/2021 - 04/2010
3	RA190IBA 01/2021 - 10/2016
3	Monoclonal AntibodiesIBA 01/2018 - 08/2008
3	CytokinesIBA 09/2016 - 07/2011
3	Neutralizing AntibodiesIBA 01/2015 - 01/2007
3	Tumor Viral Antigens (Large T Antigen)IBA 07/2013 - 10/2008
3	Poly I-CIBA 08/2011 - 07/2004
3	OvalbuminIBA 07/2011 - 07/2009
3	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 05/2009 - 10/2007
3	Small Interfering RNA (siRNA)IBA 08/2008 - 01/2005
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2024 - 01/2024
2	AlbuminsIBA 01/2024 - 10/2021
2	RNA (Ribonucleic Acid)IBA 01/2024 - 07/2004
2	Interferon Type IIBA 01/2022 - 12/2017
2	Fumarate Hydratase (Fumarase)IBA 03/2021 - 02/2020
2	Capsid Proteins (Capsid Protein)IBA 01/2021 - 01/2007
2	InterleukinsIBA 01/2021 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 11/2016
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020 - 11/2016
2	18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)FDA Link 01/2018 - 12/2007
2	ApigeninIBA 07/2017 - 05/2009
2	Interferon-gamma (Interferon, gamma)IBA 07/2017 - 03/2002
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 03/2016 - 08/2008
2	Histone Deacetylase InhibitorsIBA 01/2015 - 10/2013
2	PlatinumIBA 05/2014 - 01/2013

Therapy/Procedure

55	Immunotherapy 04/2024 - 03/2002
38	Therapeutics 04/2024 - 10/2003
21	Drug Therapy (Chemotherapy) 11/2023 - 01/2007
9	Radiotherapy 04/2024 - 05/2009
9	Investigational Therapies (Experimental Therapy) 07/2013 - 10/2007
4	Intraperitoneal Injections 05/2019 - 07/2007
2	Microspheres (Microsphere) 04/2024 - 04/2014
2	Intramuscular Injections 10/2023 - 09/2009
2	Hysterectomy 03/2021 - 02/2020
2	Lasers (Laser) 09/2015 - 04/2009